|
KMID : 0357920070410010007
|
|
Korean Journal of Pathology
2007 Volume.41 No. 1 p.7 ~ p.14
|
|
|
PPARγ Ligand-Induced Decrease of in vivo Tumor Growth Accompanied by Increased Cytolytic Activity of Splenocytes
|
|
Jang Kyu-Yun
Kim Kyung-Ryoul
Park Ho-Sung
Moon Woo-Sung
Lee Dong-Geun
Kang Myoung-Jae
Yu Ki-Hoon
Lee Hak-Yong
Choi Ha-Na
Cha Eun-Jung
|
|
|
Abstract
|
|
|
Background : Recent studies have proposed the use of peroxisome proliferator activated receptor-γ (PPARγ) ligands as new chemotherapeutic agents for human malignant tumors. However the in vivo mechanism of PPARγ ligands on cellular toxicity is not clear. Therefore we examined the anti-tumor effects of the PPARγ ligand, rosiglitazone (ROS), in animal models.
Methods : To evaluate the effect of RSO on splenocytes, an in vitro and in vivo study was performed. Cytolytic activity was measured by use of a 51Cr release assay. The splenic natural killer (NK) cell population and effector-target conjugation were measured by flow cytometric analysis.
Results : In 9L glioma bearing rats, 30 mg/kg/d of ROS treatment induced a significant decrease of subcutaneous tumor growth accompanied by an increased cytolytic activity of splenocytes and of the splenic NKR-P1bright/CD3- NK cell population. In normal rats, systemic administration of ROS also increased the cytolytic activity of splenocytes, the splenic NK cell population, and effector-target conjugation. Moreover, we found that a concentration of 20μM ROS caused an increase in the cytolytic activity of splenocytes, and a concentration of 50μM ROS increased effector-target conjugation in vitro.
Conclusion : These results suggest that increased splenic cytolytic activity and NK cell population may contribute to the anti-tumor effects of PPARγ ligands in vivo. However, the roles of NK cells in the PPARγ ligand-induced anti-tumor activity should be further investigated.
|
|
|
KEYWORD
|
|
|
Peroxisome proliferators-activator receptors, Spleen, NK cells, Glioma, Neoplasms
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|
|